This discovery linked ALS with a clinically distinct form of dementia and a larger group of microsatellite repeat diseases, and catalyzed basic and translational research.
Discoveries of novel human disease genes generate scientific interest because they open doors into understanding the causes and mechanisms of disease. It is rare, however, for a gene discovery to captivate scientists the way that the 2011 discovery of the C9orf72 expansion mutation did. In back-to-back papers published in Neuron, two independent groups led by Rademakers and Traynor reported the discovery of an intronic GGGGCC (or G 4 C 2 ) expansion mutation as the most common genetic cause of both ALS and FTD. This discovery captured the attention of scientists all over the world because it identified a common molecular cause for two clinically distinct diseases -ALS and FTD -and because it connected ALS and dementia to a large group of previously described microsatellite repeat expansion disorders.
Historically, ALS and FTD were thought to be distinct disorders. ALS is a fatal neuromuscular disorder that leads to the degeneration of upper and lower motor neurons, resulting in paralysis and eventually death. [ 1 2 7 _ T D $ D I F F ] In contrast, FTD is a neurodegenerative disease affecting primarily the frontal and anterior temporal lobes, which is characterized by behavioral changes, apathy, and dementia during the later stages of diseases. A series of separate gene mutations identified in the 1990s and 2000s as causing ALS (e.g., superoxide dismutase, SOD1) or FTD (e. g., progranulin, GRN) [ 1 2 8 _ T D $ D I F F ] were consistent with the distinct clinical features of these disorders [1, 2] . Although ALS and FTD are clinically distinct, the high frequency of their comorbidity in some families suggested a common underlying genetic mutation(s), at least in some cases. The search for the underlying gene mutation was narrowed in 2006 with the discovery of a genetic locus for familial ALS/FTD on chromosome 9p21 [3] . Eventually, in 2011, two groups independently used deep sequencing of large numbers of independent families to discover a hexanucleotide expansion in the first intron of C9orf72 gene as the leading cause of familial ALS and FTD [4, 5] . This surprising discovery created a rich scientific delta by bringing together scientists from the three separate fields of dementia, ALS, and microsatellite expansion disorders.
Two decades before the discovery of the C9orf72 expansion mutation, the microsatellite expansion field was born with the demonstration that CGG and CAG expansion mutations cause fragile X syndrome and spinal bulbar muscular atrophy (SBMA), respectively [6] . These discoveries, and the demonstration that expansion mutations can change in length when transmitted from one generation to the next, provided a molecular explanation for 'anticipation', namely the earlier onset and more severe disease in consecutive generations that are observed in many of these disorders. These discoveries also led to an intense hunt for expansion mutations in other neurologic diseases such as Huntington's disease, myotonic dystrophy, and multiple spinocerebellar ataxias. 
